Prevalence of IR % (n)

Whole Population

79.1 (129)

ATP III-MetS

88.7 (55/62)

IDF-MetS

79.3 (46/58)

SSA-MetS

84.6 (11/13)

ATP III-AO

71.4 (60/84)

IDF-AO

75.5 (102/135)

SSA-AO

91.1 (113/124)

Diabetic patients

60.3 (35/58)

Non-diabetic and non-obese patients

44.8 (47/105)